biotech
Bio-AnalystSupplement research
person

L-Theanine

Selected research topic

Sleep

Findings differ across measurements or study conditions. The results below keep them separate.

Findings from a combination study cannot be attributed to this ingredient alone.

Some findings concern patients or people with a deficiency.

Publications for this topic
15
Human comparison publications
3
Publications needing review
10

Findings in the studies

  • Insomnia symptoms

    About this measure

    Insomnia Severity Index (ISI)

    • No clear difference from the comparison group was found.

      What the comparison group used was not confirmed.

      Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Participant characteristics were not confirmed.
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • Sleep quality

    About this measure

    Pittsburgh Sleep Quality Index (PSQI) · mean score

    • No clear difference from the comparison group was found.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 6 weeks
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Results were compared between groups. · Study comparison: four-ingredient formulation versus placebo
      Additional measurement information
      Primary outcome
      Measurement time
      6 weeks
  • sleep efficiency

    • A better result than the comparison group was reported.

      What the comparison group used was not confirmed.

      Patient group · Single ingredient
      Measurement and study conditions
      Study type
      Randomized controlled trial: subjects were randomly assigned to groups for comparison.
      Study population
      Human participants · Patient group
      Ingredients tested
      Single ingredient
      How results were compared
      Results were compared between groups.
      Measurement time
      Not confirmed.
  • Sleep quality

    About this measure

    Pittsburgh Sleep Quality Index (PSQI) · total score

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.

      Several ingredients were tested together, so this ingredient’s individual effect is unknown.

      Patient group · Combination study · 4 weeks
      Measurement and study conditions
      Study type
      Clinical trial
      Study population
      Human participants · Patient group
      Ingredients tested
      Ingredient combination
      How results were compared
      Changes within the same group were compared. · Study comparison: within-group pre/post combination intake
      Additional measurement information
      Primary outcome
      Measurement time
      4 weeks
Other measured outcomes (1)
  • sleep-onset latency

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Varied across included studies
      Measurement and study conditions
      Study type
      Systematic review
      Study population
      Recorded population category: Patient group. Whether the research involved humans needs confirmation.
      Ingredients tested
      Unknown intervention
      How results were compared
      Study comparison: Mixed ADHD treatments including L-theanine; no common comparator
      Additional measurement information
      Secondary outcome
      Measurement time
      Varied across included studies

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (10)
  • morning sleepiness · Distinct papers needing additional review: 1Direction unclear: 1
  • overall subjective sleep quality score · Distinct papers needing additional review: 1Evidence criteria check: 1
  • sleep duration · Distinct papers needing additional review: 2Evidence criteria check: 2
  • sleep latency · Distinct papers needing additional review: 1Evidence criteria check: 1
  • sleep onset latency · Distinct papers needing additional review: 2Direction unclear: 1 · Evidence criteria check: 1
  • sleep problems · Distinct papers needing additional review: 1Direction unclear: 1
  • Sleep quality · Distinct papers needing additional review: 1Direction unclear: 1
  • subjective daytime dysfunction · Distinct papers needing additional review: 1Evidence criteria check: 1
  • subjective sleep onset latency · Distinct papers needing additional review: 1Evidence criteria check: 1
  • total sleep time · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Representative outcome and study details

Partial research summary

Human studies reported between-group improvement in sleep efficiency.

These conditions come from related studies and may not describe a single paper.

single- and combination-ingredient studies · Individual ingredient effects cannot be separated · Human studies · Includes patient groups · between-group comparison · comparator not confirmed

2 publications linked to this result (1 awaiting review included)

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Combination, formula, or class studies do not isolate this ingredient or establish synergy.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: C

The 9.4 evidence score includes 3 independent human studies and 3 clinical studies in the representative benefit area. The C tier remains conservative because of limited repetition across independent human clinical studies.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 97

Papers linked to this topic 15 · distinct papers 15 · papers with a confirmed human comparison 3 · papers needing additional review 10

A publication may appear in more than one count. These numbers should not be added. Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Insomnia symptoms (Insomnia Severity Index (ISI)): Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Sleep quality (Pittsburgh Sleep Quality Index (PSQI) · mean score): Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • morning sleepiness: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • overall subjective sleep quality score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sleep duration: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • sleep efficiency: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • sleep latency: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sleep onset latency: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • sleep problems: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Sleep quality: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • sleep-onset latency: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • subjective daytime dysfunction: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • subjective sleep onset latency: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Sleep quality (Pittsburgh Sleep Quality Index (PSQI) · total score): Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • total sleep time: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

What the research found

Insomnia Severity Index

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Mean PSQI

No clear difference in this measurement was found between the compared groups.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep efficiency

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total PSQI score

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep-onset latency

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

morning sleepiness

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

overall subjective sleep quality score

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep duration

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep duration

The study needs further checking before its result can be interpreted.

Animal study · indirect · Separable contribution · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep efficiency

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep latency

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep onset latency

The study needs further checking before its result can be interpreted.

Animal study · indirect · Ingredient combination · General population

This finding comes from animal or cell research. It does not establish the same effect in people.

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep onset latency

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

sleep problems

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Sleep quality

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

subjective daytime dysfunction

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

subjective sleep onset latency

The study needs further checking before its result can be interpreted.

Meta-analysis · Unknown intervention · General population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

total sleep time

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · General population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Unknown intervention · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

No combination cautions are available to show in the current data. This does not guarantee safety.

Review 1 combination findings and 0 findings that outperformed an ingredient alone.

Reported improvements with combinations

Combination findings are grouped by how the study compared them. This is not a recommendation to combine ingredients.

Combinations with reported improvement

The combination showed improvement, but each ingredient's contribution is unclear.

CaffeineL-theanine combined with caffeine significantly reduced caffeine-induced tachycardia (17% vs 92%) and state anxiety compared to caffeine alone.